glp 1 wonder Freethink What Impact will GLP-1 Agonists

Several non-invasive approaches have been developed in the past for insulin delivery [212, 213], but many of these products, particularly oral insulin products, faced challenges in clinical trials due to variable therapeutic responses owing to patient-to-patient differences in bioavailability [214-216]

Am J Gastroenterol 119(6):10281037 Osei SP, Akomaning E, Florut TF, Sodhi M, Lacy BE, Aldhaleei WA, Bhagavathula AS (2024) Gastrointestinal safety assessment of GLP-1 receptor agonists in the US: a real-world adverse events analysis from the FAERS database

References 1.Nuffield Department of Population Health Renal Studies Group

Access to weight loss drugs is a major issue and most private insurance companies consider cover for weight loss treatment as an exclusion

These costs are not temporary